OpenBilldrug price receipt

NADAC week of 2026-10-14

VERAPAMIL SR 180 MG CAPSULE

For 30 capsules

Pharmacies pay

$62.60 filed

30 × $2.08661 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$76.99 estimated

$62.60 + $9.39 (15%) + $5.00 fee per fill = $76.99

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

VERAPAMIL SR 180 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as verapamil hydrochloride.

FDA gives its dosage form as capsule, delayed release and its route as oral.

The labeler, the company named on the label, is Wilshire Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 52536-0882-01.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $62.60 for 30 capsules (30 × $2.08661 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NDC

Other strengths, forms and brands

15 other products in the NADAC file share the FDA nonproprietary name verapamil hydrochloride with VERAPAMIL SR 180 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
VERAPAMIL 40 MG TABLET
generic · tablet, film coated / tablet
$0.11259 per EA filed
eff. 2026-09-23
$0.10044 per EA filed
Part D 2024 average
VERAPAMIL 80 MG TABLET
generic · tablet, film coated / tablet
$0.07325 per EA filed
eff. 2026-09-23
$0.10044 per EA filed
Part D 2024 average
VERAPAMIL 120 MG TABLET
generic · tablet, film coated / tablet
$0.08873 per EA filed
eff. 2026-09-23
$0.10044 per EA filed
Part D 2024 average
VERAPAMIL ER 120 MG CAPSULE
generic · capsule, extended release
$2.74927 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 120 MG TABLET
generic · tablet / tablet, film coated, extended release
$0.17779 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 180 MG CAPSULE
generic · capsule, extended release
$2.08661 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 180 MG TABLET
generic · tablet / tablet, film coated, extended release
$0.19107 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 240 MG CAPSULE
generic · capsule, extended release
$3.1476 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 240 MG TABLET
generic · tablet / tablet, film coated, extended release
$0.17613 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER PM 100 MG CAPSULE
generic · capsule, extended release
$4.08287 per EA filed
eff. 2026-09-23
$5.10337 per EA filed
Part D 2024 average
VERAPAMIL ER PM 200 MG CAPSULE
generic · capsule, extended release
$5.63549 per EA filed
eff. 2026-09-23
$5.10337 per EA filed
Part D 2024 average
VERAPAMIL ER PM 300 MG CAPSULE
generic · capsule, extended release
$7.92023 per EA filed
eff. 2026-09-23
$5.10337 per EA filed
Part D 2024 average
VERAPAMIL SR 120 MG CAPSULE
generic · capsule, delayed release
$2.74927 per EA filed
eff. 2026-09-23
We don’t know yet
VERAPAMIL SR 180 MG CAPSULE this page
generic · capsule, delayed release
$2.08661 per EA filed
eff. 2026-09-23
We don’t know yet
VERAPAMIL SR 240 MG CAPSULE
generic · capsule, delayed release
$3.1476 per EA filed
eff. 2026-09-23
We don’t know yet
VERAPAMIL SR 360 MG CAPSULE
generic · capsule, delayed release
$7.80238 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $2.08661 per EA filed.

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 33 have a higher middle NADAC price and 73 a lower one; 1 has the same. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG, at $0.99481 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.